| Health / Medical Topics |
Adalimumab
A recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases. (NCI Thesaurus)
YOU MAY ALSO LIKE
Other name for diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed.
Human ADA wild-type allele is located within 20q12-q13.11 and is approximately 32 kb in length. This allele, which encodes adenosine deaminase protein,…
T cells harvested from a patient with adenosine deaminase (ADA) deficiency and transduced with a vector containing the gene for ADA. ADA…
This gene is involved in nucleotide metabolism and cellular immunity.
Autologous dendritic cells (DCs) transduced with the replication-deficient adenoviral vector Ad5F53 encoding the Epstein-Barr virus (EBV) transmembrane latent membrane proteins 1 and…
A replication-defective adenoviral-CMV vector that encodes a wild-type p53 gene. Ad5CMV-p53 induces tumor cells that have been transfected with the vector to…
